Chemoinformaics analysis of Bicyclo[10.1.0]tridec-1-ene
| Molecular Weight | 178.319 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 14 |
| Exact Molecular Weight | 178.172 | nRing | 2 |
| Solubility: LogS | -6.208 | nHRing | 0 |
| Solubility: LogP | 6.233 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 36.3794 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.48 |
| Synth | 3.268 |
| Natural Product Likeliness | 0.786 |
| NR-PPAR-gamma | 0.32 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.639 |
| MDCK | 0.0000174 |
| BBB | 0.582 |
| PPB | 0.970277 |
| VDSS | 3.29 |
| FU | 0.0153638 |
| CYP1A2-inh | 0.767 |
| CYP1A2-sub | 0.351 |
| CYP2c19-inh | 0.564 |
| CYP2c19-sub | 0.093 |
| CYP2c9-inh | 0.38 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.233 |
| CYP2d6-sub | 0.415 |
| CYP3a4-inh | 0.365 |
| CYP3a4-sub | 0.131 |
| CL | 5.029 |
| T12 | 0.117 |
| hERG | 0.01 |
| Ames | 0.019 |
| ROA | 0.03 |
| SkinSen | 0.778 |
| Carcinogencity | 0.539 |
| EI | 0.985 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.156 |
| Antiviral | Yes |
| Prediction | 0.688218 |